- Home
- COCP vs ABVC Comparison
COCP vs ABVC Comparison
Compare COCP & ABVC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COCP
- ABVC
- Stock Information
- Founded
- COCP N/A
- ABVC 2015
- Country
- COCP United States
- ABVC United States
- Employees
- COCP N/A
- ABVC N/A
- Industry
- COCP Biotechnology: Pharmaceutical Preparations
- ABVC Biotechnology: Pharmaceutical Preparations
- Sector
- COCP Health Care
- ABVC Health Care
- Exchange
- COCP Nasdaq
- ABVC Nasdaq
- Market Cap
- COCP 15.3M
- ABVC 16.7M
- IPO Year
- COCP N/A
- ABVC N/A
- Fundamental
- Price
- COCP $1.36
- ABVC $0.93
- Analyst Decision
- COCP Strong Buy
- ABVC
- Analyst Count
- COCP 1
- ABVC 0
- Target Price
- COCP $7.00
- ABVC N/A
- AVG Volume (30 Days)
- COCP 17.0K
- ABVC 282.7K
- Earning Date
- COCP 03-31-2025
- ABVC 05-16-2025
- Dividend Yield
- COCP N/A
- ABVC N/A
- EPS Growth
- COCP N/A
- ABVC N/A
- EPS
- COCP N/A
- ABVC N/A
- Revenue
- COCP N/A
- ABVC $509,788.00
- Revenue This Year
- COCP N/A
- ABVC N/A
- Revenue Next Year
- COCP N/A
- ABVC N/A
- P/E Ratio
- COCP N/A
- ABVC N/A
- Revenue Growth
- COCP N/A
- ABVC N/A
- 52 Week Low
- COCP $1.35
- ABVC $0.40
- 52 Week High
- COCP $3.26
- ABVC $1.73
- Technical
- Relative Strength Index (RSI)
- COCP 31.02
- ABVC 68.26
- Support Level
- COCP $1.38
- ABVC $0.65
- Resistance Level
- COCP $1.49
- ABVC $1.40
- Average True Range (ATR)
- COCP 0.09
- ABVC 0.10
- MACD
- COCP -0.01
- ABVC 0.05
- Stochastic Oscillator
- COCP 0.00
- ABVC 62.03
About COCP Cocrystal Pharma Inc.
Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first- and-in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI).
About ABVC ABVC BioPharma Inc.
ABVC BioPharma Inc is a clinical-stage biopharmaceuticals company with an active pipeline of six drugs and one medical device (ABV-1701/Vitargus) under development. For its drug products, it is focused on utilizing its licensed technology to conduct proof-of-concept trials through Phase II of the clinical development process. The firm is specialized in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes.